Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Karen K. Swenson"'
Autor:
Helen Garcia, Michele Darger, Shayne Hopkins, M Morrison, Mattie Anheluk, Kim Grabe, Joette Zola, Robert Kreiger, Kristin Berling, Karen K. Swenson, Mary Vining Radomski
Publikováno v:
Clinical Journal of Oncology Nursing. 25:E69-E76
Background Many cancer survivors experience cancer-related cognitive dysfunction (CRCD), which is believed to be the result of multiple contributing biologic, situational, and personal factors. Efficacious, clinically implementable interventions addr
Autor:
Susan Olet, Tamera J. Lillemoe, Barbara Susnik, Janet Krueger, Erin Grimm, Parker Martone, Natasha Rueth, Shari Baldinger, Monica Knaack, Karen K. Swenson, Michaela L. Tsai
Publikováno v:
Clinical Breast Cancer. 21:47-56
Background While breast cancer (BC) is uncommon in women ≤ age 35, women in this age group may have more aggressive cancer subtypes and high-risk pathogenic variants (HRPV). Higher recurrence and mortality rates in young patients may be related to
Autor:
Rob Kreiger, Joette Zola, Kristina Kath, Stacey Rabusch, Jerry Halsten, Mattie Anheluk, Mary Vining Radomski, Karen K Swenson, Ginger Carroll, Barbara L. Zust
Publikováno v:
Journal of Psychosocial Oncology. 38:501-509
This feasibility study evaluated the acceptability, implementability, and preliminary efficacy of a brief purpose renewal intervention (the Compass Course) using a one-group pretest-posttest design. Fifteen women who had completed treatment for early
Autor:
N Rueth, Karen K. Swenson, M Knaack, Janet Krueger, Barbara Susnik, P Martone, SR Baldinger, Michaela Tsai, Erin Grimm, Tamera J. Lillemoe
Publikováno v:
Cancer Research. 79:P5-10
Background: While breast cancer is rare in women ≤ age 35, patients in this age group are more frequently diagnosed with aggressive cancer subtypes and pathologic germline mutations in cancer susceptibility genes than older patients. Higher recurre
Autor:
Susan Olet, Tamera J. Lillemoe, Monica Knaack, Michaela L. Tsai, Janet Krueger, Mara Hester Rendi, Erin Grimm, Karen K. Swenson, Rina Yarosh, Barbara Susnik
Publikováno v:
International Journal of Breast Cancer, Vol 2021 (2021)
International Journal of Breast Cancer
International Journal of Breast Cancer
Objectives. The response to HER2-targeted neoadjuvant chemotherapy (NAC) in HER2-positive (+) breast cancer can be quantified using residual cancer burden (RCB) pathologic evaluation to predict relapse free/overall survival. However, more information
Autor:
Erinn Downs-Kelly, Barbara Susnik, Karen K. Swenson, Erin V Grimm, Hadi Yaziji, Kimberly H. Allison, Tamera J. Lillemoe, Janet Krueger, Michaela L. Tsai, Mara Hester Rendi, David G. Hicks
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 29(9)
OBJECTIVE College of American Pathologists and the American Society of Clinical Oncology guidelines provide straightforward criteria for HER2 interpretation in breast carcinomas; however, a subset of cases present unusual diagnostic dilemmas. MATERIA
Autor:
Monica Knaack, Natasha Rueth, Barbara Susnik, Tamera J. Lillemoe, Lisa Schneider, Christina Braatz, Michaela Tsai, Janet Krueger, Todd E. DeFor, Karen K. Swenson
Publikováno v:
Journal of Surgical Oncology. 118:221-227
BACKGROUND AND OBJECTIVES Preoperative breast magnetic resonance imaging (B-MRI) staging in newly diagnosed breast cancer increases detection of synchronous contralateral findings, but may result in false-positive outcomes. This study objective was t
Autor:
Michaela Tsai, Marsha Finkelstein, Janet Krueger, Erin Grimm, Barbara Susnik, S-Hl Kang, Tamera J. Lillemoe, Karen K. Swenson
Publikováno v:
Cancer Research. 77:P5-16
Background: Neoadjuvant therapy for HER2 positive invasive breast cancer is used to downstage tumor prior to surgery, objectively measure response, and evaluate novel therapies in clinical trials. Residual Cancer Burden (RCB) established by pathologi
Autor:
Margit L. Bretzke, Barbara Susnik, Deborah Day, Michaela L. Tsai, Ellen Abeln, Tara Bowman, Karen K. Swenson, Tamera J. Lillemoe, Janet Krueger
Publikováno v:
Clinical Breast Cancer. 16:507-513
Background Management recommendations for lobular neoplasia (LN) including lobular carcinoma-in-situ (LCIS) and atypical lobular hyperplasia (ALH) diagnosed in core biopsies (CB) are controversial. Our aim was to prospectively identify a subset of pa
Autor:
Michaela L. Tsai, Vivek Thumbigere-Math, Karen K. Swenson, Bryan S. Michalowicz, David L. Basi, Laura Rockwell, Pamela J. Hughes, Rajaram Gopalakrishnan
Publikováno v:
Journal of Oral and Maxillofacial Surgery. 74:738-746
To analyze serum markers of bone turnover, angiogenesis, endocrine function, and inflammation in patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ) who discontinued long-term intravenous bisphosphonate (BP) therapy.Serum samples we